News & Events

We are proud to announce that Zahrawi Group Structural Heart and Neuromodulation Unit, KSA has successfully implanted a patient with Coronary Sinus Reducer from our partner Neovasc at Al Mouwasat hospital, Dammam. The patient underwent 10 years ago a coronary artery bypass graft, with diabetes & hypertension history and has chest pain despite optimal medication […]

Read more

We are pleased to announce that Zahrawi Group Bahrain was awarded “Partner Of The Year” by our partner Beckman Coulter Life Sciences. Our Bahrain team received the award as a recognition of their hard work after they successfully placed the very first Beckman Coulter Life Sciences CytoFLEX SRT sorter in all middle east region at […]

Read more

Zahrawi Group held its 2022 Kick-Off meeting in the presence of UAE, KSA, Qatar, Bahrain & Oman leadership teams during the month of February.  For the first time, this function is held in one meeting on Group level and across all countries. Abdulrahman Ramadan, Group Vice President & Acting CEO presented an overview of the […]

Read more

We are pleased to announce that Zahrawi Group Molecular, Immunology & Microbiology team received an award in recognition for their QuantiFERON Achievements in 2021 handed by our partner Qiagen. Zahrawi Group started the distribution of Qiagen QuantiFERON in Q2 – 2021 and we succeeded in growing the business in a very short time demonstrating a […]

Read more

Zahrawi Group took the lead since the COVID-19 Pandemic in 2020 to provide all the possible solutions for the COVID-19 patients. Antibody level testing helps clinicians to establish whether patients have immunity against COVID-19 which impacts the nature of the treatment and the vaccine needed for them. DiaSorin provided the most comprehensive, accurate, and quantitative […]

Read more